EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00.
Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and Priv.-Doz. Dr. med. Clemens Kösters.
Date: 16 November 2022
Time: 1:00 p.m. to 4:00 p.m
Place: Redeye, Mäster Samuelsgatan 42, Stockholm
There will be physical slots available. For physical slots please register at: https://www.lyyti.fi/reg/Capital_Markets_Day_Episurf_0954
Follow the event digitally at: www.redeye.se
Welcome!
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
[HtmlContact:protected] => <p><strong><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">For more information, please contact:</span></span></span></strong></p>
<p><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">Pål Ryfors, CEO, Episurf Medical</span></span></span><br>
Tel:<span style="font-size:10pt">+46 (0) 709 62 36 69</span><br>
<span style="font-size:10pt">Email: </span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></span></span></span></p>
<p><span><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">Veronica Wallin, CFO, Episurf Medical</span></span></span></span><br>
<span><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">Tel:</span></span></span></span><span><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">+46 (0) 700 37 48 95</span></span></span></span><br>
<span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">Email: </span></span></span><a href="mailto:pal.ryfors@episurf.com"><span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">veronica.wallin@episurf.com</span></span></span></a></p>
[HtmlTitle:protected] => <h1 style="line-height:120%"><span style="font-family:arial,helvetica,sans-serif">Episurf Medical invites to a Capital Markets Day, November 16, 2022</span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00.
Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and Priv.-Doz. Dr. med. Clemens Kösters.
Date: 16 November 2022
Time: 1:00 p.m. to 4:00 p.m
Place: Redeye, Mäster Samuelsgatan 42, Stockholm
There will be physical slots available. For physical slots please register at: https://www.lyyti.fi/reg/Capital_Markets_Day_Episurf_0954
Follow the event digitally at: www.redeye.se
Welcome!
[HtmlBody:protected] => <p style="margin-top:12px"><span style="font-size:10pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00.</span></span></span></span></p>
<p><span style="font-size:10pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and Priv.-Doz. Dr. med. Clemens Kösters.</span></span></span></span></p>
<p><span style="font-size:10pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">Date: 16 November 2022<br>
Time: 1:00 p.m. to 4:00 p.m<br>
Place: Redeye, Mäster Samuelsgatan 42, Stockholm</span></span></span></span></p>
<p style="margin-bottom:11px"><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">There will be physical slots available. For physical slots please register at: </span></span><a href="https://www.lyyti.fi/reg/Capital_Markets_Day_Episurf_0954" style="color:#0563c1; text-decoration:underline"><span style="font-family:arial,helvetica,sans-serif">https://www.lyyti.fi/reg/Capital_Markets_Day_Episurf_0954</span></a></span></span></p>
<p><span style="font-size:10pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">Follow the event digitally at: </span></span><span style="color:black"><a href="http://www.redeye.se" style="color:#0563c1; text-decoration:underline"><span style="font-family:arial,helvetica,sans-serif">www.redeye.se</span></a></span> </span></span></span></p>
<p><span style="font-size:10pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">Welcome!</span></span></span></span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 14747
)
[2] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 14326
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
[Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
Veronica Wallin, CFO, Episurf Medical
Tel:+46 (0) 700 37 48 95
Email: veronica.wallin@episurf.com (pal.ryfors@episurf.com)
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3663993/1658474.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Episurf Medical invites to a Capital Markets Day, November 16, 2022
[Description:protected] => Episurf Medical invites to a Capital Markets Day, November 16, 2022
[CreateDate:protected] => 2022-11-09T07:30:19.717Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 4395500
[EncryptedId:protected] => FD85230ECAB31F85
[IsRegulatory:protected] =>
[PublishDate:protected] => 2022-11-09T07:30:00Z
[LastChangeDate:protected] => 2022-11-09T07:30:19.7Z
[Title:protected] => Episurf Medical invites to a Capital Markets Day, November 16, 2022
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-invites-to-a-capital-markets-day--november-16--2022,c3663993
[LanguageVersions:protected] => Array
(
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)